Embarazo y leucemia mieloide crónica tratada con imatinib.

Autor: Báez-de la Fuente, Enrique¹ ebaez@axtel.net, Arellano-Severiano, Baltazar¹

Publikováno v: Revista Medica del IMSS. jul-ago2014, Vol. 52 Issue 4, p342-345. 4p.

Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available

Autor: Foltz, Lynda, Pica, Gian-Matteo, Zerazhi, Hacene, Van Droogenbroeck, Jan, Visanica, Sorin, Báez de la Fuente, Enrique, Leber, Brian, de Almeida, Antonio Medina, Ranta, Dana, Kiladjian, Jean-Jacques, Chrit, Linda, Kandra, Albert, Morando, Juliane, Devos, Timothy

Publikováno v: Leukemia & Lymphoma; Dec2019, Vol. 60 Issue 14, p3493-3502, 10p

Updated Results from an Open-Label, Multicenter, Expanded Treatment Protocol (ETP) Phase (Ph) 3b Study of Ruxolitinib (RUX) in Patients (Pts) with Polycythemia Vera (PV) Who Were Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatment (Tx) Was Available

Autor: Foltz, Lynda, Pica, Gian-Matteo ^*, Zerazhi, Hacene ^*, Van Droogenbroeck, Jan ^*, Visanica, Sorin ^*, Báez de la Fuente, Enrique ^*, Leber, Brian, de Almeida, Antonio Medina ^*, Ranta, Dana ^*, Cartes, Mauricio Reyes ^*, Kiladjian, Jean-Jacques, Chrit, Linda ^*, Yin, Zhaoyu ^*, Morando, Juliane ^*, Devos, Timothy

Publikováno v: In Blood 29 November 2018 132 Supplement 1:1774-1774

Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas?

Autor: Ramirez Lopez, Alba Nydia, Baez De La Fuente, Enrique ^*, De Leon Cantu, Rosa Elva ^*, Cruz Contreras, Diego ^*, Carrizalez Villarreal, Jose Alfredo ^*, Cedillo De La Cerda, Jose Luis ^*, Saldaña Vazquez, Roxana ^*, Sorkee Davila, Helga Patricia ^*, Rosas Rodríguez, Axel Eduardo ^*, Baltazar Arellano, Severiano ^*, Hernandez Valdes, Roberto ^*, Lafarga Amao, Bernardo ^*, Lozano, Rosa ^*, Terrazas, Andrea ^*

Publikováno v: In Blood 8 December 2017 130 Supplement 1:5520-5520

[Nilotinib in patients with chronic myeloid leukemia without response to imatinib].

Autor: Báez-de la Fuente E; Servicio de Hematología, Hospital de Especialidades 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, México. ebaez@axtel.net., Arellano-Severiano B

Publikováno v: Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2014 May-Jun; Vol. 52 (3), pp. 330-3.